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The lymphocyte Fc receptor has been demonstrated on B cells and a subpopu- 
lation ofT cells in the mouse (1), but the functional role of  this receptor is not yet 
clearly established. Since there is evidence that the ability of  immune complexes 
to inhibit antibody responses is dependent on an intact antibody Fc fragment 
(2),  we have considered the possible role of the Fc receptor in this inhibition. 
Moller and Coutinho (3) has shown that soluble antigen-antibody complexes do 
not affect the  action  of polyclonal  B-cell  activators.  Previous data from this 
laboratory,  however,  demonstrated  that  immobilized  antigen-antibody  com- 
plexes have the ability to inhibit mitogenesis, and that the inhibition is depend- 
ent on an intact Fc fragment and is not mediated by soluble complexes (4). In the 
present report, we have extended these experiments to investigate the mecha- 
nism of  the inhibition of DNA synthesis in mitogen-stimulated lymphocytes and 
to show that under certain conditions the in vitro generation of plaque-forming 
cells (PFC) ~ by LPS may also be inhibited by immobilized complexes. 
Materials and Methods 
Mice.  BALB/c mice, 6-10-wk old,  were obtained from the Animal Production Unit, National 
Institutes of Health. Congenitally athymic nu/nu BALB/c mice were obtained from Charles River 
Breeding Laboratories, Inc., Wilmington, Mass. 
Mitogens.  8 bromo-3',5'-cyclic guanosine monophosphoric acid (8 BrcGMP) was obtained from 
Sigma Chemical Co., St. Louis, Mo. Lipopolysaccharide (LPS) was obtained from Difco Laborato- 
ries,  Detroit, Mich.  (Escherichia  coli 0111:B4 or E. coli 055:B5,  prepared by the Westphal tech- 
nique). 
Cell Preparation.  Mouse spleens were removed aseptically,  teased with sterile forceps,  and 
dispersed  by passage  through  a  no.  20  hypodermic  needle  five times.  The  cells were  filtered 
through sterile nylon gauze to remove clumps, washed once in balanced salt solution (BSS), and 
suspended in culture  medium.  Sheep red blood cells (SRBC) were obtained from the National 
Institutes of Health animal farm, stored in Alsever's solution, and washed in BSS twice before use 
in cultures. 
Culture Conditions.  A  modified Mishell-Dutton culture system was used.  5  x  10  -~ cells/well 
were cultured in 5% CO2 at 37°C for 4 days in 200 t~l of medium in flatbottom Microtest II plates, 
Falcon Plastics, Oxnard, Calif. The microtiter plates were first coated with mouse serum albumin 
(MSA),  modified  by  trinitrobenzenesulfonic  acid  to  put  trinitrophenol  (TNP)  groups  on  the 
protein,  and  then  coated  with  rabbit anti-dinitrophenol-bovine serum  albumin obtained  from 
Miles Laboratories, Kanakee, Ill. Details of this procedure for creating a  surface of immobilized 
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complexes have been published (4). No feeding or rocking was used during the culture period. 
Each sample was set up in a complete row (12 replicates), and all replicates were combined when 
harvested. Standard Mishell-Dutton medium with 5 x  10 -s M 2-mercaptoethanol supplementation 
was used.  Viability varied between 25 and 50% after 4 days in culture. In many experiments the 
FCS was omitted or replaced with 0.5% syngeneic normal mouse serum which was prepared fresh 
each day. 
Assay.  Anti-SRBC  plaques  were  counted  in  a  modified  Jerne  plaque  assay  (5).  Mitogen 
experiments were pulsed with [3H]thymidine and harvested on day 3 as described previously (4). 
Antibody Preparations.  F(ab')2 fragments from affinity purified rabbit anti-TNP antibodies 
were  prepared  with  pepsin  as  before  (4).  Soluble  complexes  were  prepared  by  incubating 
TNP33MSA with rabbit anti-TNP IgG in fourfold antigen excess (determined by a precipitin curve) 
for 1 h  at 37°C. 
Results 
Kinetics  of the Inhibition of LPS Mitogenic Activity by Immobilized Com- 
plexes.  The activity of mitogens acting on cells bearing the Fc receptor was 
shown to be profoundly inhibited by immobilized complexes when mitogenesis 
was assayed on day 3 of the culture period (4). The kinetics of this inhibition of 
mitogenesis  by the  B-cell  mitogen  LPS  has  been  examined  (Fig.  1).  These 
results show that the mitogenic activity is inhibited throughout a culture period 
of 7 days. Thus the previously observed inhibition on day 3 was not due to an 
alteration in the peak time of response to LPS. 
Inhibition of the Mitogenic Effect of 8 BrcGMP.  Derivatives of cGMP have 
been shown to induce DNA synthesis in mouse B lymphocytes (6). Though there 
is no experimental evidence, one may speculate that this effect may reflect an 
intracellular  increase in cGMP, a  proposed intracellular  regulator of cell divi- 
sion. Since such a mitogenic mechanism would not obviously involve cell surface 
receptors,  the effect of immobilized complexes on thymidine incorporation  in- 
duced by 8 BrcGMP was tested. A striking inhibition of the mitogenic effect of 
this compound was observed over a  wide concentration range  (Fig. 2). 
Inhibition of  LPS Mitogenesis in Athymic Mice.  One possible interpretation 
of the inhibition of mitogenesis by immobilized complexes is that an Fc receptor- 
positive T  cell (7) may become activated to become an effective suppressor cell 
capable of inhibiting mitogenesis in B cells. Since such suppressor T cells have 
been found lacking in congenitally athymic (nu/nu)  mice (8), the inhibition of 
LPS-induced  mitogenesis  was  tested  with  spleen  cells from  these mice.  The 
degree of inhibition by immobilized complexes in these cultures was comparable 
to that achieved using normal spleen cells (Fig. 3) (4) and was entirely depend- 
ent on an  intact  Fc fragment  in the antibody molecule.  Thus it appears that 
suppressor T cells are unlikely to play a role in mediating the observed inhibi- 
tion. 
Effect of  Immobilized Antigen-Antibody Complexes on the LPS-Induced Poly- 
clonal Antibody Response.  LPS has been shown to be a  potent polyclonal B- 
cell activator in that it can induce B  cells to differentiate nonspecifically into 
antibody-secreting  cells  (9).  It  was  of interest  to  see  if this  activation  was 
inhibited  by immobilized complexes in a  manner  similar to that observed for 
mitogenesis.  When the cultures were carried out in the absence of serum,  the 
generation  of PFC was inhibited  an  average of 76%  (Table I).  Inhibition  was 
observed in  every experiment  and  was  highly  significant.  Immobilized  com- 770  ANTIGEN-ANTIBODY  COMPLEXES  AND  B-CELL  ACTIVATION 
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FIG.  I.  Kinetics of  LPS mitogenesis and its  inhibition  by immobilized complexes. Identi- 
cal cultures were set up and harvested on specified  days. Each culture was pulsed with I 
/~Ci [3H]thymidine  (2 Ci/mM) 24 h before harvesting. Thymidine incorporation was mea- 
sured in the presence of  immobilized antigen (O),  (MSA-TNP), and immobilized antigen- 
antibody complexes (C)),  (MSA-TNP-AB).  Error bars indicate the standard error of the 
mean of  quadruplicate wells. 
plexes  made with F(ab')2  antibodies  had an insignificant  effect  (11% inhibition). 
Soluble  complexes, used at  a concentration  of  5/~g/ml of  antibody,  had a similar 
insignificant effect (15% inhibition). 
When similar cultures were carried out in medium containing 0.5% syngeneic 
normal mouse serum, the PFC response and its inhibition (90%) were similar to 
those observed in serum-free medium (Table I). Heat-inactivated (56°C, 30 min) 
fresh mouse serum could also be used to support cultures, with similar inhibi- 
tion observed. This was tested to rule out possible inhibitory effects of comple- 
ment  binding  to  the  C3  receptor  after  being  activated  by the  immobilized 
complexes. If medium containing 5% FCS was used, however, the results were 
markedly different. In this case, the PFC response to LPS was similar to that 
obtained in serum-free medium and with 0.5% NMS, but no significant inhibi- 
tion by immobilized complexes was observed. 
Since all previous experiments demonstrating  the inhibition  of mitogenesis 
had been carried out in the absence of added serum, it was of interest to examine 
the effect of xenogeneic serum (fetal calf serum,  FCS) on this process. Table II 
shows an  experiment  in which  LPS  stimulation  was  carried  out in  medium 
containing  5%  FCS.  The  background  level of thymidine  incorporation  in the 
absence of added LPS was approximately 10 times that observed in serum-free 
medium. In the presence of immobilized complexes this background was reduced 
nearly 50%. The LPS-stimulated incorporation levels were unaffected by immo- 
bilized complexes. 
In other experiments (data not shown) it was found that a SRBC-induced PFC 
response could only be obtained in the presence of 5% FCS, but not in 0.5% NMS 
or serum-free medium.  Thus we were unable to effectively test the ability of 
immobilized complexes to inhibit antigen-induced PFC in medium where inhibi- 
tion  of proliferation  could be  demonstrated.  There  was  no  inhibition  of the 
SRBC-induced response in FCS containing cultures. JOHN  L.  RYAN  AND  PIERRE  A.  HENKART  771 
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Fro.  2.  Stimulation of spleen cells by 8 BrcGMP. Cells were cultured in the presence of 
immobilized complexes (MSA-TNP-AB),  (O); and in the presence of immobilized antigen 
(MSA-TNP),  (I). F(ab')2 control is shown (MSA-TNP-F(ab')=),  (A). Cells were pulsed for 24 
h with 1 ;tCi [3H]thymidine  (2 Ci/mM) and harvested on day 3. 
30,000 
10,000 
a.  3000 
~9 
E  ~  1000 
I- 
"1" 
300 
100 
_  _  ,  p 
I  I  I  1  l 
10  20  30  40  50 
LPS, ~g/ml 
FIG. 3.  Stimulation of athymic (nu/nu)  spleen cells by LPS.  Cells were cultured in the 
presence of immobilized complexes (MSA-TNP-AB),  (C), and in the presence of immobilized 
antigen (MSA-TNP),  (D); F(ab')2  control is shown (MSA-TNP-F(ab')2),  (A). 
The ability of immobilized complexes to inhibit B-cell activation in the pres- 
ence  of FCS  was  further examined  in  athymic (nu/nu)  spleen cell  cultures 
(Table III). The polyclonal response induced by LPS was measured in serum-free 
medium and in medium containing 5% FCS. In this case immobilized complexes 
were able to inhibit the LPS response effectively  in both serum-free medium and 772  ANTIGEN-ANTIBODY  COMPLEXES  AND  B-CELL  ACTIVATION 
TABLE  I 
Inhibition of LPS B-Cell Activation by Immobilized Complexes 
Culture conditions  0.1% BSA  0.5% NMS  5% FCS 
PFC/IO  ~*  PFC/IO  6 
MSA-TNP$  0  0  21  _+  10 
MSA-TNP-Ab§  0  0  23  -  6 
MSA-TNP$ +  LP$1  59  _+  14  48  _+  19  49  -+ 8 
MSA-TNP-Ab§ +  LP~I  14  _+  5  4 +_  2  51  +  10 
* Results are given for direct anti-SRBC PFC/10  ~ recovered cells on day 4 of  culture. All are _+ SE 
for six separate experiments. 
$ Refers to culture wells with immobilized antigen (TNP-modified MSA). 
§ Refers to culture wells with immobilized antigen-antibody complexes. 
II  10 ~g/ml LPS/well. 
TABLE II 
Lack of Inhibition of LPS Mitogenesis in the Presence of FCS* 
Culture conditions  cpm 
MSA-TNP$  15,350  _+  210 
MSA-TNP$ +  LPS  29,800  _+  453 
MSA-TNP-Ab§  8,714  _+  112 
MSA-TNP-Ab§ +  LPS  27,420  +  846 
* DNA synthesis measured between 48-72  h.  10  ~g/ml LPS added to 
appropriate wells, cpm are -  SE. 
Refers to culture wells with immobilized antigen. 
§ Refers to culture wells with immobilized antigen-antibody complexes. 
in the presence of 5%  FCS.  Thus FCS  may interfere with the  inhibition of 
normal spleen cells by immobilized complexes, but does not abrogate the inhibi- 
tion of athymic (nu/nu) spleen cell cultures. When 1:1 mixtures of nu/nu spleen 
cells and normal BALB spleen cells were tested, it was found that immobilized 
complexes did not exert a significant inhibitory effect in the presence of 5% FCS 
(data not shown). 
Discussion 
These results demonstrate that the inhibition of LPS-induced mitogenesis by 
immobilized antigen-antibody complexes is present throughout the culture pe- 
riod and is probably not due to suppressor T cells. Since it has been shown that 
all B-cell activators tested are inhibited by immobilized complexes (4), one may 
argue that blocking of surface receptors is not the mechanism of inhibition. The 
experiments with  8  BrcGMP-induced mitogenesis may further support  the 
interpretation that this Fc receptor-mediated inhibition does not operate by 
blocking surface receptors for mitogen, but by induction of an intracellular "off' 
signal. This assumes that exogenously added cGMP derivatives are able to act 
as intracellular signals for proliferation. This hypothesis, while supported by 
some data (10), cannot presently be accepted as proven. 
In the absence of FCS, immobilized complexes are able to mediate the inhibi- 
tion of polyclonally stimulated antibody production by normal spleen cell cul- 
tures.  This  inhibition  is  highly dependent on an  intact Fc fragment in  the 
complexes and  is  not mediated by  soluble complexes. This  confirms results JOHN  L.  RYAN  AND  PIERRE  A.  HENKART 
TABLE III 
Inhibition  of the Polyclonal Antibody Response in Athymic (nu/nu) 
Mice 
773 
Culture conditions  5% FCS (4 exp)  0.1%  BSA (5 exp) 
PFC  /I O  6. 
MSA-TNP$  30  -+  11  2 _+  2 
MSA-TNP-Ab§  2 -+  1  0 
MSA-TNP* +  LPS[  87  -+  12  66  -+  14 
MSA-TNP-Ab§ +  LPS[  19  -+  11  23  -+  11 
* PFC/106  recovered cells on day 4 of culture. All results are -+ SE. 
Refers to culture wells with immobilized antigen. 
§ Refers to culture wells with immobilized antigen-antibody complexes. 
II  10/~g/ml LPS/well. 
obtained earlier by other workers (3) and extends our previous work on inhibi- 
tion of  B-cell mitogenesis (4). When nude spleen cells were cultured it was found 
that they could be equally inhibited in the presence or absence of FCS.  This 
raises many questions concerning the role of FCS in in vitro culture systems. 
The components of FCS which are supportive are still poorly defined (11). The 
difference in the ability of immobilized complexes to inhibit PFC in normal and 
nude spleen cell cultures in the presence of FCS suggests that the serum may be 
stimulating T cells present in normal spleen populations and absent in athymic 
spleen populations. It is this T-cell stimulation that may overcome the inhibi- 
tory effect of the complexes, since the B cells in both populations are apparently 
intact (12). In the presence of both FCS and the polyclonal B-cell activator LPS, 
the positive signals to the B cell may overcome the off signal generated by the 
immobilized complexes. The lack of inhibition observed when the nude and 
normal cells were tested as a mixture in the presence of FCS may support this 
interpretation.  Further work with separated cell populations and  separated 
serum components will be necessary to elucidate these phenomena. 
The inhibition of the polyclonal activation of spleen cells by immobilized 
complexes  appears  to  be  associated  with  an  inhibition  of the  proliferative 
response of the LPS-responsive cell population. This follows from the correlation 
between inhibition of mitogenesis and inhibition of PFC formation in the serum- 
free system and the inability of the immobilized complexes to inhibit either 
DNA synthesis or PFC formation in normal spleen cells in the presence of FCS. 
None of the experiments reported have dealt with inhibition of antigen-specific 
responses. It may be more difficult to demonstrate the inhibition of T-dependent 
responses in this system because of the ability of FCS to block the inhibition. 
The off signal delivered to  T-cell-stimulated B  lymphocytes by immobilized 
antigen-antibody complexes may be inadequate to turn off the B cell.  Coordi- 
nated  binding  to  both  the  Fc  receptor and  surface immunoglobulin might 
generate an off signal which would be sufficient to turn off the B cells involved 
(13). 
The success that has been achieved in many in vitro systems in inhibiting 
antibody responses with specific antibody (14) has been suggested to be due to 
antigen removal. Our data would suggest that binding of complexes to B cells 
via  their Fc receptors is  critical  for regulation, but  that  more than  simple 774  ANTIGEN-ANTIBODY  COMPLEXES  AND  B-CELL  ACTIVATION 
binding of  complexes is necessary. Perhaps complexes could be formed in vivo on 
antigen-carrying cells such as macrophages and interact with B-cell Fc receptors 
and surface immunoglobulin simultaneously. Clonal proliferation is an essen- 
tial characteristic of immune responses and a feedback inhibition of  the prolifer- 
ation of a specific clone is a desirable mechanism for control. 
Summary 
Immobilized antigen-antibody complexes are  able  to  inhibit the mitogenic 
response of murine spleen cells to the B-cell mitogen 8-bromo-3',5'-cyclic guano- 
sine monophosphoric acid. This inhibition is dependent on intact Fc fragments 
in the immobilized complexes. Soluble complexes do not mediate this inhibition. 
When lipopolysaccharide (LPS) activation of B cells was studied, it was found 
that the mitogenic response was inhibited at all times tested between 2 and 7 
days of culture. Also,  the LPS-induced mitogenesis of nude spleen cells was 
inhibited by immobilized complexes, indicating that suppressor T cells probably 
play no significant role in the inhibition. Immobilized complexes inhibit poly- 
clonal antibody responses in a serum-free system and in the presence of normal 
mouse serum, but are unable to inhibit in the presence of  fetal calf serum (FCS). 
Ifnu/nu spleen cells are used, however, the FCS does not block the ability of  the 
complexes  to  inhibit the  polyclonal response.  It  is  suggested that  antigen- 
antibody complexes under appropriate conditions may bind to B lymphocytes via 
their Fc receptors and trigger a  central "off" signal which blocks proliferation 
and consequently antibody production. 
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